Matrix metalloproteases (MMPs) are Zn-containing endopeptidases involved in the degradation of extracellular matrix components and are typically secreted in a latent (pro-MMP) form and activated either by proteolytic or oxidative disruption of a conserved cysteine switch. Several recent studies have suggested that nitric oxide (NO) can contribute to the activation of MMPs, but the mechanisms involved are incompletely understood. We investigated the ability of NO to regulate the activation of (pro)MMP-9 using a variety of NO-donor compounds and characterized modifications of the cysteine switch using a synthetic peptide (PRCGVPDLGR) representing the cysteine switch domain of MMP-9. Among the NO-donors used, only S-nitrosocysteine (SNOC) was found to be capable of modest activation of proMMP-9, but S-nitrosoglutathione (GSNO) or the NONOates, DEA-NO, SPER-NO, or DETA-NO, were ineffective. In fact, high concentrations of DETA-NO were found to inhibit MMP-9 activity, presumably by direct interaction with the active-site Zn 2+ . Analysis of chemical modifications within the Cys-containing peptide, PRCGVPDLGR, revealed rapid and transient S-nitrosylation by SNOC and GSNO, and formation of mixed disulfides and dimerized peptide as major final products. Similarly, NONOates induced transient S-nitrosylation and primarily peptide dimerization. Coordination of the peptide Cys with a synthetic Zn 2+ complex, to more closely mimic the structure of the active site in proMMP-9, reduced peptide nitrosylation and oxidation by NONOates, but enhanced peptide nitrosylation by SNOC and GSNO. Collectively, our results demonstrate that NO is incapable of directly activating proMMP-9 and that S-nitrosylation of MMP-9 propeptide by NO-donors is unrelated to their ability to regulate MMP-9 activity.Matrix metalloproteinases (MMPs) comprise a family of zinc-containing endopeptidases and play important roles in development, inflammation, tissue injury and repair, and tumor biology (1,2). The MMP family consists of at least 26 members that share several structural characteristics including a highly conserved Cys-containing pro-peptide domain and a catalytic domain containing three His residues bound to a Zn(II) metal ion. MMPs are typically expressed at low levels in normal tissues, but in conditions of inflammation and/or tissue injury, MMP expression is generally increased by the action of pro-inflammatory † This work was supported by NIH research grants R01 HL074295 and R01 HL068865 (to A.vdV.), T32 ES07122 (training fellowship to S.M.M.), and P20 RR16462 (to the Vermont Genetics Network). Several recent studies have suggested that NO contributes to the activation of MMPs or related metalloproteinases by S-nitrosylation (often also referred to as S-nitrosation) of the pro-domain Cys residue. For example, MMP-9 activation in vivo was found to be associated with increased NOS activity, and the nitrosothiol S-nitrosocysteine is capable of activating pro-MMP-9 by a mechanism that appears to involve transnitrosylation (4,11). Similar...